PAR
Click for more information
1.79% 27.5¢ paradigm biopharmaceuticals limited..

Most phase II trials are also for new untested drugs. They often...

  1. Sojourner
    6,512 Posts.
    lightbulb Created with Sketch. 1912
    clock Created with Sketch.
    19/11/19
    18:47
    Post #: 41514925
    Most phase II trials are also for new untested drugs. They often fail because of adverse events.

    PPS is not a new drug. It's repurposed and been in use in humans for many decades.

    Given those factors the odds change dramatically in PAR's favour.
    Last edited by Sojourner: 19/11/19
    PAR Price at posting: $3.75 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PMT High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%
right-arrow Created with Sketch.
CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
NEWS Good debt vs bad debt for the property in your investment portfolio
right-arrow Created with Sketch.
ENR Encounter Resources flags latest niobium hits in fresh assay data
right-arrow Created with Sketch.
MGT Magnetite Mines set to progress DFS for Razorback through deal with JFE Shoji
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
27.5¢ 		Change
-0.005(1.79%) 		Mkt cap ! $96.19M
Open High Low Value Volume
28.5¢ 28.5¢ 27.0¢ $55.31K 200.8K

Buyers (Bids)

No. Vol. Price($)
2 1072 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.5¢ 3289 1
View Market Depth
Last trade - 16.10pm 10/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.